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TO THE EDITOR
The standard method for assessment of
an individual’s sensitivity to UVR is by
visual determination of the minimal
erythema dose (MED). However, MED
assessment is subjective and its accuracy
is particularly challenged in pigmented
skin, as the observers’ ability to perceive
erythema decreases with increasing skin
pigmentation (Diffey and Robson, 1992;
Lock-Andersen and Wulf, 1996). The
application of reflectance spectrometry
permits objective measurements of UVR-
erythema, with identification of threshold
doses following construction of dose-
response curves (Diffey et al., 1984;
Farr and Diffey, 1984). However, in
practice, it is challenging to give high
enough UVR doses in very pigmented
skin to elicit incremental erythema
responses and to detect these responses
through an epidermis dense with
melanin, which absorbs light increa-
singly below 800 nm (Zonios et al.,
2008). Kollias et al. (1994) explored the
use of laser Doppler velocimetry (at
632.8 nm) in measuring UVR response
as red blood cell flux (scattering Doppler-
shifted laser light) and concluded that
signals are difficult to differentiate from
background in darkly pigmented indivi-
duals. However, Abbot et al. (1996)
reported that detection at wavelengths
in the near-infrared (780/830 nm)
minimizes interference by melanin.
On the basis of these earlier studies,
we explored the possibility of detecting
a minimal sunburn reaction (vasodilata-
tion) irrespective of pigmentation by a
technique for fast imaging of perfusion
using a 785 nm laser, a wavelength
minimally absorbed by melanin. The
technique is dubbed ‘‘laser speckle
contrast imaging’’ and is receptive to
the Doppler-shifted backscatter from
moving red blood cells (Supplementary
Text online). Instead of time-consuming
precision scanning with the laser beam,
the method simply quantifies the
blurring (loss of contrast by rapid fluc-
tuations) in different parts of the speckle
pattern, by processing an image of the
(expanded) laser spot in ‘‘real-time’’ to
visualize spatial and temporal variations
in perfusion. The contrast K in a small
area e.g., 5 5 pixels is defined as K¼
s/oI4, where s is the standard devia-
tion andoI4 the average intensity, and
assigned to the central pixel. Assuming
local ergodicity, K is inversely propor-
tional to the fluctuation rate in a pixel
(Kpwidth of autocorrelation; Briers
et al., 2013). Thus, K1 increases with
increasing velocity and a number of
erythrocytes––i.e., flux––which can be
visualized in false color images.
Table 1. Summary of subject phototype I–VI demographics and UVR responses
Skin phototype I II III IV V VI1
Number of subjects 2 5 4 2 8 10
Gender (male/female) 2/0 1/4 1/3 0/2 6/2 3/7
Age±SD (years) 34±13 35±13 39±18 25±4 32±13 33±8
L* at assessment site 71.5±1.0 70.0±2.9 69.4±3.5 64.3±4.3 50.0±6.2 40.6±5.2
MFD and MED within 1 UVR dose-step (cases) 2/2 4/5 4/4 1/2 4/8 6/10
MED±SD (mJ cm 2) 21.0±0 27.8±9.8 30.8±2.5 52.5±3.5 91.3±22.3 181.7±158.3
MFD±SD (mJ cm 2) 16.5±1.5 22.6±8.9 31.0±5.7 43.0±8.3 56.4±13.5 103.5±37.2
Abbreviations: L*, skin lightness; MED, minimum erythema dose; MFD, minimum flux dose.
1One participant did not demonstrate erythema for visual assessment (Figure 1b).
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Ethical approval for this study was
gained from the University of Manche-
ster Ethics committee and NRES North
West–GM West. Written informed con-
sent was obtained from all volunteers,
whose demographics are summarized in
Table 1. A handheld spectrophotometer
(CM-600D; Konica Minolta, Osaka,
Japan) was used to measure skin color
at baseline and after UVR-irradiation.
A geometric series of 10 UVR doses,
with increment B30%, was applied to
sun-protected skin (upper buttock or
upper inner arm; see Supplementary
Text online) with a predominantly
UVB source (TL-20W/12, Philips,
Eindhoven, The Netherlands or UV6,
Waldmann, Villingen-Schwenningen,
Germany) and with erythemally
weighted doses in ranges of 7–80 to
53–600 mJ cm2 dependent on photo-
type. Assessments were made at 24 hour
post UVR, with the MED defined
as the UVR dose producing a just
perceptible erythema and ‘‘minimal flux
dose’’ (MFD) as the lowest UVR dose at
which a threshold increase in blood
flux was exceeded. Flux measurements
were made with a laser speckle
contrast imager (FLPI-2, Moor Instru-
ments, Axminster, UK) in temporal
mode, calibrated against static and
thermally moving polystyrene micro-
spheres in a vessel provided by
the manufacturer. Flux images were
presented as a video in real time. Aver-
aging over multiple heart pulses,
video images (selecting 20–60 seconds
without subject movement at 20
milliseconds camera exposure time,
sampled over 1 or 4 seconds intervals)
were stacked into a single image. Aver-
age flux values were determined in a
demarcated circular area at the center of
each of the 10 phototested sites and in
immediately adjacent control sites––i.e.,
10 control sites.
In white skin subjects (phototypes
I–III), the background flux ratios (FR;
flux in test field/flux in control field)
below one MED averaged 1.04 with SD
0.12. The threshold for a significant
increase in FR was therefore set at 1.3
(meanþ2SD, rounded off), and MFD
was determined by interpolation to
FR¼1.3 over a line segment connecting
the two measured points of FR versus
log (UV dose) bracketing this threshold.
The MFD so determined (equating to
30% increase in flux) was within one
dose-step of the MED in 91% of photo-
type I–III (Table 1). In contrast, only
56% of phototype V and VI demon-
strated an MFD within one dose-step of
the MED. With increased pigmentation,
i.e., lower L* (‘‘Lightness’’), there was an
increasing discrepancy between MED
and MFD (Figure 1a, Table 1). On the
extreme end of the scale, the darkest
skin (L*¼32.1) phototested showed no
visible erythema while demonstrating
increased blood flux for several UVR
dose-steps (Figure 1b). The steepness of
increase in FR with log (UV dose) tended
to decrease with increasing MFD
(Figure 1c), consistent with reported
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Figure 1. Minimum flux dose assessment using 785nm laser contrast imager and relationship to MED and
skin color. (a) The ratio between MED and MFD versus L* (Lightness, first color coordinate in L*a*b* color
space). Skin lightness has a greater influence on the difference in sensitivity between MED and MFD in darker
skin (L*o55). (b) Comparison of laser speckle-derived flux images (bottom row) and photographs (top row) of
UVR-treated sites (each UVR site was marked by black marker pen) in 2 individuals. It is striking that in the
pigmented individual (right column), no visual erythema could be detected, whereas in contrast the flux
images demonstrated responses to several doses of UVR. (c) The steepness in the FR response with increasing
dose (4MFD) is represented by the slope FR/log10(UV dose) on the log-scaled y axis (labeled ‘‘FR/logUV
slope’’) and plotted versus MFD on a log-scaled x axis. This graph shows a trend of decreasing steepness in
flux response with increasing MFD toward the higher phototypes; ‘‘FR/logUV slope’’¼ –0.6141 log(MFD)
þ1.744; R2¼ 0.43. FR, flux ratio; MED, minimal erythema dose; MFD, minimal flux dose.
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influence of MC-1R variants and pigmen-
ted skin on UVR-blood flow dose-
response (Young et al., 1985; Flanagan
et al., 2001). In view of an encouraging
report, we also explored the possibility of
using a* (‘redness’), a hemoglobin (Hb)
index, and Hb oxygen (HbO2) saturation
gained with a standard spectrophoto-
meter (CM-600D; Konica Minolta) to
describe erythemal responses (Kollias
et al., 1994). However, we found that
they by no means reached the level of
reliability of the MFD in assessing
minimal sunburn in pigmented skin
(Supplementary Figure 1a–d online).
MFD permits objective assessment
of UVR-vasodilatation response, which
is transferable between laboratories.
Although our data suggest that 30% flux
increase is a good threshold for MFD,
this should be verified in a larger study
with more extensive MED and MFD
assessments. Laser speckle contrast ima-
ging appears to be more sensitive and
more reliable compared with other
available objective methods, such as
determining oxyhemoglobin levels from
reflectance spectra. Hence, we find
785 nm laser speckle contrast imaging
excellently suited to assess robustly a
minimal sunburn reaction (by vasodila-
tation) even in heavily pigmented skin.
Influence of skin pigmentation on UVR
responses is an area of substantial cur-
rent interest and controversy (Brenner
and Hearing, 2008; Bogh et al., 2010;
Farrar et al., 2011), and this technique
will assist its further exploration.
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TO THE EDITOR
Se´zary syndrome (SS) is an aggressive
cutaneous T-cell lymphoma charac-
terized by high numbers of neoplastic
T cells in peripheral blood, lymph nodes,
and skin. Optimal therapy is challenging
and prognosis is poor with an overall
5-year survival of around 25%.
Alemtuzumab is a humanized IgG1
mAb directed against the CD52 antigen,
a 21–28 kDa cell surface glycoprotein
attached to the cell membrane by
a glycosylphosphatidyl-inositol (GPI)
anchor. CD52 is expressed on T and B
lymphocytes, natural killer cells, mono-
cytes, and some dendritic cells. In vitro
studies showed that alemtuzumab inducesAccepted article preview online 28 November 2014; published online 8 January 2015
Abbreviations: GPI, glycosylphosphatidyl-inositol; PNH, paroxysmal nocturnal hemoglobinuria; SCT, stem
cell transplantation; SS, Se´zary syndrome
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